Personalis, Inc. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Amendment No. 2 to the Commercialization and Reference Laboratory Agreement, dated September 20, 2024, by and between Personalis, Inc. and Tempus AI, Inc (Filed With SEC on November 6, 2024)
- Amendment No. 1 to the Commercialization and Reference Laboratory Agreement, dated August 16, 2024, by and between Personalis, Inc. and Tempus AI, Inc (Filed With SEC on August 16, 2024)
- Form of Option Agreement under 2020 Inducement Plan (Filed With SEC on February 28, 2024)
- Form of RSU Award Agreement under 2020 Inducement Plan (Filed With SEC on February 28, 2024)
- Personalis, Inc. 2020 Inducement Plan, as amended (Filed With SEC on February 28, 2024)
- Commercialization and Reference Laboratory Agreement, between Personalis, Inc. and Tempus Labs, Inc., dated November 25, 2023 (Filed With SEC on November 28, 2023)
- Amended and Restated Offer Letter, dated March 7, 2023, between the Company and Christopher Hall (Filed With SEC on March 8, 2023)
- Contract No. 36C24E22D0031, by and between the U.S. Department of Veterans Affairs and the Registrant, dated September 30, 2022 (Filed With SEC on November 2, 2022)
- Description of Securities of Personalis, Inc (Filed With SEC on February 25, 2021)
- Description of Securities of Personalis, Inc (Filed With SEC on March 25, 2020)
- Pricing Agreement, by and between Illumina, Inc. and the Registrant, dated March 26, 2019 (Filed With SEC on May 23, 2019)
- Pricing Agreement, by and between Illumina, Inc. and the Registrant, dated November 22, 2017 (Filed With SEC on May 23, 2019)
- Contract No. VA240-17-D-0103, by and between the U.S. Department of Veterans Affairs and the Registrant, dated September 28, 2017 (Filed With SEC on May 23, 2019)
